Table 1 |
||
|
Primer sequences for the present study |
||
|
Primer |
Sequence (5' to 3') |
|
|
|
||
|
Sense |
Antisense |
|
|
|
||
|
TβRI |
TTAAAAGGCGCAACCAAGAAC |
GTGGTGATGAGCCCTTCGAT |
|
TβRII |
GACATCAATCTGAAGCATGAGAACA |
GGCGGTGATCAGCCAGTATT |
|
Smad2 |
GCTGTTTTCCTAGCGTGGCTT |
TCCAGACCCACCAGCTGACT |
|
Smad3 |
GCATCAGCCGCTTCTCAAGT |
ATCTCCCCACCATCACCTCC |
|
Smad4 |
CCTTCTGGAGGAGATCGCT |
TCAATGGCTTCTGTCCTGTGG |
|
Smad7 |
AATGTGTTTTCTAGATTCCCAACTTCTT |
CACTCTCGTCTTCTCCTCCCAGTA |
|
Sp1 |
AGAATTGAGTCACCCAATGAGAACA |
GTTGTGTGGCTGTGAGGTCAAG |
|
COL2A1 |
GGCAATAGCAGGTTCACGTACA |
CGATAACAGTCTTGCCCCACTT |
|
COL1A1 |
CACCAATCACCTGCGGTACAGAA |
CAGATCACGTCATCGCACAAC |
|
COL10A1 |
CCTGGTATGAATGGACAGAAAGG |
CCCTGAGGGCCTGGAAGA |
|
Aggrecan |
TCGAGGACAGCGAGGCC |
TCGAGGGTGTAGCGTGTAGAGA |
|
Sox9 |
CCC ATG TGG AAG GCA GAT G |
TTC TGA GAG GCA CAG GTG ACA |
|
|
||
|
Baugé et al. Arthritis Research & Therapy 2011 13:R23 doi:10.1186/ar3247 |
||
